Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Chemotherapy Patients”

8,837 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,837 results

Testing effectiveness (Phase 2)Study completedNCT01471470
What this trial is testing

Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Asan Medical Center 31
Testing effectiveness (Phase 2)WithdrawnNCT04611776
What this trial is testing

A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Hoffmann-La Roche
Large-scale testing (Phase 3)Ended earlyNCT04503668
What this trial is testing

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Who this might be right for
Gynecologic Cancer
University of Michigan Rogel Cancer Center 62
Testing effectiveness (Phase 2)Looking for participantsNCT06249191
What this trial is testing

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaHigh Grade B-Cell Lymphoma
OHSU Knight Cancer Institute 30
Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Testing effectiveness (Phase 2)UnknownNCT00003827
What this trial is testing

Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
ALZA 25
Large-scale testing (Phase 3)Study completedNCT04449861
What this trial is testing

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 166
Testing effectiveness (Phase 2)Ended earlyNCT02379585
What this trial is testing

Fasting on Newly Diagnosed Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Western Regional Medical Center 8
Testing effectiveness (Phase 2)Ended earlyNCT00126243
What this trial is testing

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

Who this might be right for
AIDS Related Lymphoma
French National Agency for Research on AIDS and Viral Hepatitis 60
Testing effectiveness (Phase 2)WithdrawnNCT00728585
What this trial is testing

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Who this might be right for
Gastrointestinal MucositisMalignant Neoplasm
Children's Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07360743
What this trial is testing

Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

Who this might be right for
Non Small Cell Lung Cancer (Squamous or Non Squamous)
UNICANCER 275
Large-scale testing (Phase 3)UnknownNCT02001896
What this trial is testing

Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation

Who this might be right for
Non-Small Cell Lung Cancer
Xinjiang Medical University 60
Large-scale testing (Phase 3)Ended earlyNCT00662688
What this trial is testing

Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityPancreatic CancerThromboembolism
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Not applicableStudy completedNCT00410488
What this trial is testing

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

Who this might be right for
SarcomaNauseaVomiting
M.D. Anderson Cancer Center 51
Large-scale testing (Phase 3)Study completedNCT00049517
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 657
Testing effectiveness (Phase 2)Study completedNCT04271813
What this trial is testing

Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)

Who this might be right for
Colorectal CancerImmunotherapyAnlotinib+3 more
Shanghai Changzheng Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04060459
What this trial is testing

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Third Military Medical University 50
Testing effectiveness (Phase 2)UnknownNCT05541146
What this trial is testing

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

Who this might be right for
Gastric CancerPeritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo 30
Testing effectiveness (Phase 2)Study completedNCT02307227
What this trial is testing

Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors

Who this might be right for
Breast Neoplasms
Centro di Riferimento Oncologico - Aviano 46
Early research (Phase 1)Study completedNCT01969643
What this trial is testing

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Who this might be right for
HER2 Positive Breast NeoplasmsHormone Receptor Positive Breast NeoplasmsTriple Negative Breast Neoplasms+1 more
Seagen Inc. 290
Load More Results